title: Cost-Effectiveness of Sitagliptin Versus Sulfonylurea As An Add-On Therapy To Metformin In Patients With Type 2 Diabetes In A Belgium Setting.
authors.affiliation: Merck Research Laboratories, North Wales, PA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.affiliation: Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
authors.forename: L
authors.initials: L
authors.lastname: Radican
authors.affiliation: Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
authors.forename: R
authors.initials: R
authors.lastname: Shankar
authors.affiliation: MSD Belgium BVBA, Brussels, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Hiver
authors.affiliation: Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Qiu